The hepatitis C virus (HCV) has been shown to cause progressive and chronic liver damage.1 Interferon therapy apparently eradicates HCV in 20 to 30 percent of patients, but the follow-up in published studies is generally short (6 to 18 months) and never exceeds 3 to 5 years. Our findings indicate that at the doses used, interferon has little, if any, long-term efficacy in patients with chronic hepatitis C.
Lack of sustained efficacy of interferon in patients with chronic hepatitis C
CONCIA, Ercole;
1996-01-01
Abstract
The hepatitis C virus (HCV) has been shown to cause progressive and chronic liver damage.1 Interferon therapy apparently eradicates HCV in 20 to 30 percent of patients, but the follow-up in published studies is generally short (6 to 18 months) and never exceeds 3 to 5 years. Our findings indicate that at the doses used, interferon has little, if any, long-term efficacy in patients with chronic hepatitis C.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
